Johnson Pharmacare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, sales was INR 32.63 million. Revenue was INR 32.63 million. Net income was INR 4.58 million compared to net loss of INR 1.01 million a year ago. Basic earnings per share from continuing operations was INR 0.0082 compared to basic loss per share from continuing operations of INR 0.0018 a year ago. Diluted earnings per share from continuing operations was INR 0.0082 compared to diluted loss per share from continuing operations of INR 0.0018 a year ago.